13 — HUTCHMED (China) Income Statement
0.000.00%
Last trade - 00:00- HK$20.35bn
- HK$14.66bn
- $630.20m
Annual income statement for HUTCHMED (China), fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 228 | 356 | 426 | 838 | 630 |
| Cost of Revenue | |||||
| Gross Profit | 39.5 | 97.9 | 115 | 454 | 281 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 425 | 563 | 834 | 825 | 679 |
| Operating Profit | -197 | -207 | -408 | 12.6 | -48.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -111 | -155 | -361 | 106 | 45.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -116 | -167 | -360 | 101 | 38.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -126 | -195 | -361 | 101 | 37.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -126 | -195 | -361 | 101 | 37.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.18 | -0.246 | -0.426 | 0.122 | 0.048 |